Dr. Kulig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1601 E 19th Avenue
Denver, CO
Denver, CO 80238Phone+1 303-525-9068Fax+1 855-879-1423- Is this information wrong?
Summary
- Dr. Clark Kulig is a Transplant Hepatologist in Denver, CO and works exclusively with Presbyterian/St. Luke's Transplant Service, which has the best liver transplant waitlist and one year liver graft survival in Colorado. He received his medical degree from University of Wisconsin School of Medicine and Public Health. He completed medical residency at OHSU in Portland, Oregon and then Addiction and Gastroenterology and Hepatology Fellowships in Denver. He has been in practice 19 years. He specializes in Transplant Hepatology and has enjoyed founding Transplant Hepatology outreach clinics in Billings, Montana; Casper Wyoming, Albuquerque, New Mexico, as well as Loveland, Colorado Springs and Grand Junction, Colorado. He has taught hundreds of medical students, residents and fellows. He has 9 publications and over 150 citings. Dr. Kulig is proud to bring his multidisciplinary liver transplant team’s expertise to patients with liver disease across the Rocky Mountain West from Canada to Mexico.
Education & Training
- University of ColoradoFellowship, Gastroenterology, 2003 - 2006
- Oregon Health & Science UniversityResidency, Internal Medicine, 1998 - 2001
- University of Wisconsin School of Medicine & Public HealthClass of 1998
Certifications & Licensure
- OR State Medical License 1999 - Present
- MT State Medical License 2016 - 2026
- NM State Medical License 2024 - 2026
- CO State Medical License 2001 - 2025
- WY State Medical License 2017 - 2024
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- 6 citationsU.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 PatientsSamuel B. Ho, Bashar Aqel, Eric Dieperink, Shanglei Liu, Lori Tetrick, Yngve Falck-Ytter, Charles DeComarmond, C. Smith, Daniel P. McKee, William P. Boyd, Clark C. Kul...> ;Digestive Diseases and Sciences. 2011 Jan 11
- 19 citationsThe spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.Gregory T. Everson, Mitchell L. Shiffman, Timothy R. Morgan, John C. Hoefs, Richard K. Sterling, D. A. Wagner, Clark C. Kulig, Teresa M. Curto, Elizabeth C. Wright> ;Alimentary Pharmacology & Therapeutics. 2008 May 1
- 5 citationsControlling for serum albumin level improves the correlation between serum fatty acid ethyl esters and blood ethanol level.John-Paul Morfin, Clark C. Kulig, Gregory T. Everson, Thomas P. Beresford> ;Alcoholism, Clinical and Experimental Research. 2007 Feb 1
- Join now to see all
Press Mentions
- Presbyterian/St. Luke's Medical Center Expands Transplant Services with Addition of Liver ProgramAugust 26th, 2015
Grant Support
- Quantitative Liver Function In Early Fibrosis Stage HCV InfectionNational Center For Research Resources2007–2008
Hospital Affiliations
- Presbyterian/St. Luke's Medical CenterDenver, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: